Patents by Inventor Marc J. Kirchmeier

Marc J. Kirchmeier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for therapeutic agents
    Patent number: 11167032
    Abstract: The present disclosure provides inter alia compositions that comprise therapeutic agents (e.g., live attenuated viral antigens, therapeutic proteins, etc.) and a lipid component. The lipid component may comprise or consist of different types of lipid or lipids as described herein. In some embodiments the therapeutic agents are thermolabile. The present disclosure also provides methods for preparing compositions, including the aforementioned compositions (e.g., melt methods and spray injection methods among others).
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: November 9, 2021
    Assignee: Variation Biotechnologies Inc.
    Inventors: Marc J. Kirchmeier, David E. Anderson
  • METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS
    Publication number: 20180228899
    Abstract: The present disclosure provides inter alia compositions that comprise therapeutic agents (e.g., live attenuated viral antigens, therapeutic proteins, etc.) and a lipid component. The lipid component may comprise or consist of different types of lipid or lipids as described herein. In some embodiments the therapeutic agents are thermolabile. The present disclosure also provides methods for preparing compositions, including the aforementioned compositions (e.g., melt methods and spray injection methods among others).
    Type: Application
    Filed: April 18, 2018
    Publication date: August 16, 2018
    Inventors: Marc J. Kirchmeier, David E. Anderson
  • METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS
    Publication number: 20150079077
    Abstract: The present disclosure provides inter alia compositions that comprise therapeutic agents (e.g., live attenuated viral antigens, therapeutic proteins, etc.) and a lipid component. The lipid component may comprise or consist of different types of lipid or lipids as described herein. In some embodiments the therapeutic agents are thermolabile. The present disclosure also provides methods for preparing compositions, including the aforementioned compositions (e.g., melt methods and spray injection methods among others).
    Type: Application
    Filed: January 25, 2013
    Publication date: March 19, 2015
    Inventors: Marc J. Kirchmeier, David E. Anderson
  • METHOD FOR DETERMINING COMPATIBILITY OF AN ACTIVE PHARMACEUTICAL INGREDIENT WITH MATERIALS
    Publication number: 20100216667
    Abstract: Disclosed is a system or matrix approach for determining compatibility of a pharmaceutically active substance, such as small molecule drug candidate, therapeutic proteins, peptides, vaccines or RNAi, with materials used in the research and development of pharmaceuticals, including plastics, polymers, resins, rubbers, elastomers, glass and steel.
    Type: Application
    Filed: December 17, 2009
    Publication date: August 26, 2010
    Inventors: Brian K. Meyer, Leonardo R. Allain, David Geer, Rajiv Mahajan, David R. Walker, Marc J. Kirchmeier